R-Roscovitine, a potential cancer drug on trial, known for killing certain immune cells, can exacerbate symptoms associated with asthma according to experts from the Edinburgh University.

It was revealed that this drug may prove its additional worth apart from being used for treating cancer by proving effective for treating asthma in patients who are resistant to asthma steroid treatment.

From News.bbc.co.uk:

The scientists studied the effect the drug had on immune cells known as eosinophils.

Eosinophils, found in the lungs and airways, help the body fight off parasitic infection.

‘Unwanted side-effects‘

However, too many uncontrolled eosinophils can damage other cells that line the lung, contributing to inflammatory conditions such as asthma.

Researchers found that use of the drug caused the eosinophil cells to undergo a form of cell death known as apoptosis, a natural process where unwanted cells are removed from the body.

Professor Adriano Rossi, of the centre for inflammation research at Edinburgh University who directed the study, remarked that use of R-Roscovitine can be considered as an alternative to steroids that are often accused of unwanted side effects. It was also revealed that the cancer drug on trial can be used in conjunction with steroid treatment for asthma patients.

Bookmark It

Hide Sites

Tags: Asthma, cancer drug, R-roscovitine, steroid, steroids

Posted in Steroid Cycles, Steroids and Anabolic Steroids, buy steroids, steroid nation